Literature DB >> 9327755

Role of free apolipoprotein A-I in cholesterol efflux. Formation of pre-alpha-migrating high-density lipoprotein particles.

B Asztalos1, W Zhang, P S Roheim, L Wong.   

Abstract

This article characterizes products formed by the interaction of purified apolipoprotein (apo) A-I and human fibroblasts. Fibroblasts were incubated with different concentrations of purified apoA-I (1 to 30 micrograms/mL) in tissue culture medium for different periods of time (0 to 24 hours). The medium was then characterized by one- (agarose) and two-dimensional (agarose: polyacrylamide nondenaturing gradient gel) electrophoresis. At any given concentration of apoA-I, the rate of cellular cholesterol efflux appeared linear over 24 hours. Incubating purified apoA-I with fibroblasts for 4 hours, we detected five pre-alpha lipoproteins with particle sizes between 114 and 684 kDa. Formation of pre-alpha lipoproteins was concentration-dependent. At low concentrations (below 5 micrograms/mL apoA-I), all purified apoA-I (with pre-beta mobility) was converted to pre-alpha lipoproteins. At higher concentrations (greater than 5 micrograms/mL apoA-I), more apoA-I remained with pre-beta mobility. The pre-alpha lipoproteins were characterized by colocalization of apoA-I particles with 14C-cholesterol and 32P-phospholipids. Results showed that the pre-alpha particle of lowest molecular weight contained phospholipid and apoA-I but no cholesterol. The remaining pre-alpha particles contained all three substances. When pre-alpha particles were subjected to ultracentrifugation, all particles floated at d < 1.21 g/mL with some of the smallest phospholipid apoA-I only particles being present in the d > 1.21 g/mL fraction. Based on these results, we postulated that in the first stages of reverse cholesterol transport, pre-alpha lipoproteins are formed by the interaction of lipid free apoA-I and peripheral cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9327755     DOI: 10.1161/01.atv.17.9.1630

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  8 in total

Review 1.  Lipidomics as a tool for the study of lipoprotein metabolism.

Authors:  Anatol Kontush; M John Chapman
Journal:  Curr Atheroscler Rep       Date:  2010-05       Impact factor: 5.113

Review 2.  Alterations in lipoprotein defense against oxidative stress in metabolic syndrome.

Authors:  Boris Hansel; Anatol Kontush; Dominique Bonnefont-Rousselot; Eric Bruckert; M John Chapman
Journal:  Curr Atheroscler Rep       Date:  2006-11       Impact factor: 5.113

3.  Circulating Nef induces dyslipidemia in simian immunodeficiency virus-infected macaques by suppressing cholesterol efflux.

Authors:  Bela F Asztalos; Zahedi Mujawar; Matthew P Morrow; Angela Grant; Tatiana Pushkarsky; Christine Wanke; Richard Shannon; Matthias Geyer; Frank Kirchhoff; Dmitri Sviridov; Michael L Fitzgerald; Michael Bukrinsky; Keith G Mansfield
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

4.  Triacylglycerol-rich lipoproteins alter the secretion, and the cholesterol-effluxing function, of apolipoprotein E-containing lipoprotein particles from human (THP-1) macrophages.

Authors:  E M Lindholm; A M Palmer; A Graham
Journal:  Biochem J       Date:  2001-06-01       Impact factor: 3.857

5.  Nascent high density lipoproteins formed by ABCA1 resemble lipid rafts and are structurally organized by three apoA-I monomers.

Authors:  Mary G Sorci-Thomas; John S Owen; Brian Fulp; Shaila Bhat; Xuewei Zhu; John S Parks; Dharika Shah; W Gray Jerome; Mark Gerelus; Manal Zabalawi; Michael J Thomas
Journal:  J Lipid Res       Date:  2012-06-29       Impact factor: 5.922

6.  Niacin extended-release/simvastatin combination therapy produces larger favorable changes in high-density lipoprotein particles than atorvastatin monotherapy.

Authors:  Peter P Toth; Kamlesh M Thakker; Ping Jiang; Robert J Padley
Journal:  Vasc Health Risk Manag       Date:  2012-01-25

7.  Impact of high-density lipoprotein 3 cholesterol subfraction on periprocedural myocardial injury in patients who underwent elective percutaneous coronary intervention.

Authors:  Kazuhiro Harada; Ryosuke Kikuchi; Susumu Suzuki; Akihito Tanaka; Toshijiro Aoki; Naoki Iwakawa; Hiroki Kojima; Kenshi Hirayama; Takayuki Mitsuda; Takuya Sumi; Yosuke Negishi; Hideki Ishii; Toyoaki Murohara
Journal:  Lipids Health Dis       Date:  2018-02-02       Impact factor: 3.876

8.  Macrophage-independent regulation of reverse cholesterol transport by liver X receptors.

Authors:  Sarah R Breevoort; Jerry Angdisen; Ira G Schulman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-06-19       Impact factor: 8.311

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.